Long-Term Clinical Results Following Stenting of the Left Main Stem Insights From RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries

被引:49
|
作者
Onuma, Yoshinobu [1 ]
Girasis, Chrysafios [1 ]
Piazza, Nicolo [1 ]
Garcia-Garcia, Hector M. [1 ]
Kukreja, Neville [1 ]
Garg, Scot [1 ]
Eindhoven, Jannet [1 ]
Cheng, Jin-Ming [1 ]
Valgimigli, Marco [2 ]
van Domburg, Ron [1 ]
Serruys, Patrick W. [1 ]
机构
[1] Erasmus MC, Thoraxctr, NL-3015 CE Rotterdam, Netherlands
[2] Univ Ferrara, Cardiovasc Inst, I-44100 Ferrara, Italy
关键词
coronary disease; stents; atherosclerosis; PERCUTANEOUS CORONARY INTERVENTION; ASSOCIATION TASK-FORCE; ARTERY-DISEASE; AMERICAN-COLLEGE; SYNTAX SCORE; BARE-METAL; IMPLANTATION; BIFURCATION; GUIDELINES; OUTCOMES;
D O I
10.1016/j.jcin.2010.03.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We investigated the long-term clinical outcomes and independent predictors of major cardiac events in unprotected left main coronary artery disease (ULMCA) patients treated by percutaneous coronary intervention with drug-eluting stent (DES). Background There is limited information on long-term (>3 years) outcomes after DES implantation for ULMCA. Furthermore, bifurcation angle and SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score are emerging as parameters for patient risk stratification, and their prognostic implications have still to be elucidated. Methods One hundred forty-eight patients with ULMCA treated with DES were analyzed and compared with a historical cohort of 79 patients who received bare-metal stents for the treatment of ULMCA. Patient-oriented composite end point was defined as the occurrence of all-cause death, any myocardial infarction, or any revascularization. Results The 4-year cumulative incidence of all-cause death, any myocardial infarction, any revascularization, and patient-oriented composite were 35.6%, 3.8%, 25.2%, and 54.4%, respectively. These end points had relatively increased from 1 year to 4 years by Delta 70%, Delta 5%, Delta 50%, and Delta 68%, respectively. When compared with a historical cohort who received bare-metal stents for ULMCA treatment, landmark analysis performed after the first 2 years of follow-up demonstrated that the DES cohort had significantly higher patient-oriented composite end point over the last 2 years of follow-up (26% vs. 8%, p = 0.02). EuroSCORE (European System for Cardiac Operative Risk Evaluation), cardiogenic shock, and SYNTAX score were identified as independent predictors for the 4-year patient-oriented composite, whereas bifurcation angle was not. Conclusions Late increase in patient-oriented composite end points after DES implantation for ULMCA warrants careful and long-term follow-up. SYNTAX score and EuroSCORE appear to have a significant prognostic value in long-term patient risk. (J Am Coll Cardiol Intv 2010;3:584-94) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:584 / 594
页数:11
相关论文
共 10 条
  • [1] Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease - Insights from the rapamycin-eluting and Taxus Stent evaluated at Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH)
    Valgimigli, M
    van Mieghem, CAG
    Ong, ATL
    Aoki, J
    Granillo, GAR
    McFadden, EP
    Kappetein, AP
    de Feyter, PJ
    Smits, PC
    Regar, E
    Van der Giessen, WJ
    Sianos, G
    de Jaegere, P
    Van Domburg, RT
    Serruys, PW
    CIRCULATION, 2005, 111 (11) : 1383 - 1389
  • [2] Impact of Sex on 3-Year Outcome After Percutaneous Coronary Intervention Using Bare-Metal and Drug-Eluting Stents in Previously Untreated Coronary Artery Disease Insights From the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries
    Onuma, Yoshinobu
    Kukreja, Neville
    Daemen, Joost
    Garcia-Garcia, Hector M.
    Gonzalo, Nieves
    Cheng, Jin Ming
    van Twisk, Piet Hein
    van Domburg, Ron
    Serruys, Patrick W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (07) : 603 - 610
  • [3] Comparison of Six-Year Clinical Outcome of Sirolimus- and Paclitaxel-Eluting Stents to Bare-Metal Stents in Patients with ST-Segment Elevation Myocardial Infarction: An Analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus Stent Evaluated at Rotterdam Cardiology Hospital) Registries
    Simsek, Cihan
    Magro, Michael
    Boersma, Eric
    Onuma, Yoshinobu
    Nauta, Sjoerd
    Daemen, Joost
    Gaspersz, Marcia
    van Geuns, Robert-Jan
    van der Giessen, Willem
    van Domburg, Ron
    Serruys, Patrick
    JOURNAL OF INVASIVE CARDIOLOGY, 2011, 23 (08): : 336 - 341
  • [4] The Unrestricted Use of Sirolimus- and Paclitaxel-Eluting Stents Results in Better Clinical Outcomes During 6-Year Follow-Up Than Bare-Metal Stents An Analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus Stent Evaluated At Rotterdam Cardiology Hospital) Registries
    Simsek, Cihan
    Magro, Michael
    Boersma, Eric
    Onuma, Yoshinobu
    Nauta, Sjoerd T.
    Gaspersz, Marcia P.
    van der Giessen, Willem J.
    van Domburg, Ron T.
    Serruys, Patrick W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (10) : 1051 - 1058
  • [5] Five-Year Clinical Outcomes After Coronary Stenting of Chronic Total Occlusion Using Sirolimus-Eluting Stents: Insights From the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital - (Research) Registry
    Shen, Zhu Jun
    Garcia-Garcia, Hector M.
    Garg, Scot
    Onuma, Yoshinobu
    Schenkeveld, Lisanne
    van Domburg, Ron T.
    Serruys, Patrick W.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 74 (07) : 979 - 986
  • [6] Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world" -: The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry
    Lemos, PA
    Serruys, PW
    van Domburg, RT
    Saia, F
    Arampatzis, CA
    Hoye, A
    Degertekin, M
    Tanabe, K
    Daemen, J
    Liu, TKK
    McFadden, E
    Sianos, G
    Hofma, SH
    Smits, PC
    van der Giessen, WJ
    de Feyter, PJ
    CIRCULATION, 2004, 109 (02) : 190 - 195
  • [7] Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents:: Insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital -: (RESEARCH) registry
    Garcia-Garcia, Hector M.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (05) : 635 - 639
  • [8] Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients - An evaluation from the Rapamycin-Eluting Stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) study
    Lemos, PA
    Hoye, A
    Goedhart, D
    Arampatzis, CA
    Saia, F
    van der Giessen, WJ
    McFadden, E
    Sianos, G
    Smits, PC
    Hofma, SH
    de Feyter, PJ
    van Domburg, RT
    Serruys, PW
    CIRCULATION, 2004, 109 (11) : 1366 - 1370
  • [9] A quantitative coronary angiography-matched comparison between a prospective randomised multicentre cutting balloon angioplasty and bare metal stent trial (REDUCE III) and the Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESEARCH) study
    Ozaki, Yukio
    Lemos, Pedro A.
    Yamaguchi, Tetsu
    Suzuki, Takahiko
    Nakamura, Masato
    Ismail, Tevfik F.
    Kitayama, Michihiko
    Nishikawa, Hideo
    Kato, Osamu
    Serruys, Patrick W.
    EUROINTERVENTION, 2010, 6 (03) : 400 - 406
  • [10] The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry)
    Lemmert, Miguel E.
    van Mieghem, Nicolas M.
    van Geuns, Robert-Jan
    Diletti, Roberto
    van Bommel, Rutger J.
    van Domburg, Ron T.
    de Jaegere, Peter P.
    Regar, Evelyn
    Zijlstra, Felix
    Boersma, Eric
    Daemen, Joost
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 240 : 103 - 107